The new Intellectual Property Rights policy in India seeks to make patent filing more accessible to Indian innovators. The policy highlights the need for legal reforms and targeted initiatives to boost innovation and patent activity in the country.
Read more about New Intellectual Property Rights to ease Patent filingCategory: Patents
True Position Inc.’s Device Locator Patent Invalidated
The USPTO’s PTAB has invalidated True Position Inc.’s device locator patent 7,783,299 on grounds of anticipation and obviousness based on prior art. Polaris Wireless successfully challenged the patent’s validity, highlighting the significance of robust prior art analysis in US patent law.
Read more about True Position Inc.’s Device Locator Patent InvalidatedWhat makes Samsung want to buy Blackberry?
Samsung’s reported interest in acquiring Blackberry highlights the value of Blackberry’s patent portfolio and strategic assets. The potential deal faces regulatory scrutiny in Canada and could impact competition in the smartphone industry.
Read more about What makes Samsung want to buy Blackberry?‘Killead’s Patent Application Killed by the Indian Patent Office!
Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C treatments in India.
Read more about ‘Killead’s Patent Application Killed by the Indian Patent Office!Roche’s backbone rendered brittle by Indian Patent Office
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects of Indian pharmaceutical patent law and its impact on international drug companies.
Read more about Roche’s backbone rendered brittle by Indian Patent OfficeWeekly IP Warm-UP!
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and court decisions with clarity and factual accuracy.
Read more about Weekly IP Warm-UP!Drug Humira turns Rheumatic for Abbott Biotechnology
The Indian Patent Office set aside Abbott Biotechnology’s Humira patent after Glenmark’s pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges to Humira patents both in India and globally.
Read more about Drug Humira turns Rheumatic for Abbott BiotechnologyRPX acquires patents owned by Apple’s Rockstar Consortium for US$ 900M
RPX Corp. is acquiring around 4,000 patents from Apple’s Rockstar Consortium for US$ 900 million, effectively ending several major patent lawsuits. This deal highlights a move from litigation to licensing in managing high-value technology patents.
Read more about RPX acquires patents owned by Apple’s Rockstar Consortium for US$ 900MAstrazeneca to retain Sweetness of Onglyza
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement of Saxagliptin hydrochloride patents before their expiry.
Read more about Astrazeneca to retain Sweetness of OnglyzaPatent licensing agreement for Google and Verizon
Google and Verizon have entered a five-year patent licensing agreement to prevent litigation over patent infringements. The deal aims to reduce exposure to patent trolls and support innovation across various technologies.
Read more about Patent licensing agreement for Google and Verizon